Cardlytics Inc
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-… Read more
Cardlytics Inc (CDLX) - Total Liabilities
Latest total liabilities as of September 2025: $297.51 Million USD
Based on the latest financial reports, Cardlytics Inc (CDLX) has total liabilities worth $297.51 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cardlytics Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how Cardlytics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cardlytics Inc Competitors by Total Liabilities
The table below lists competitors of Cardlytics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
H&R GmbH & Co. KGaA
XETRA:2HRA
|
Germany | €531.54 Million |
|
Vittia Fertilizantes
SA:VITT3
|
Brazil | R$312.37 Million |
|
Trk Corp
TW:1432
|
Taiwan | NT$4.36 Billion |
|
GenoFocus Inc
KQ:187420
|
Korea | ₩88.25 Billion |
|
Lotus Bakeries NV
PINK:LOTBY
|
USA | $676.63 Million |
|
Firma Oponiarska DĘBICA SA
WAR:DBC
|
Poland | zł1.03 Billion |
|
ANGLE plc
OTCQX:ANPCF
|
USA | $6.39 Million |
|
Solasia Pharma K.K
F:9SO
|
Germany | €588.00 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Cardlytics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -63.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.02 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cardlytics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cardlytics Inc (2015–2024)
The table below shows the annual total liabilities of Cardlytics Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $322.72 Million | -26.55% |
| 2023-12-31 | $439.35 Million | -8.40% |
| 2022-12-31 | $479.63 Million | -16.31% |
| 2021-12-31 | $573.10 Million | +115.98% |
| 2020-12-31 | $265.35 Million | +227.40% |
| 2019-12-31 | $81.05 Million | -20.38% |
| 2018-12-31 | $101.79 Million | -67.11% |
| 2017-12-31 | $309.44 Million | +1.89% |
| 2016-12-31 | $303.69 Million | +24.24% |
| 2015-12-31 | $244.45 Million | -- |